BP
ALKS icon

Ballentine Partners’s Alkermes ALKS Stock Holding History

Ballentine Partners’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,023
Closed -$655K – 140
2014
Q2 		$655K Buy
13,023
+23
+0.2% +$1.06K 0.08% 63
2014
Q1 		$573K Hold
13,000
– – 0.07% 70
2013
Q4 		$529K Buy
+13,000
New +$480K 0.06% 76

Other funds holding ALKS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Ballentine Partners's ALKS Position: Q3 2014 in Review

Ballentine Partners sold out of Alkermes (ALKS) in Q3 2014, closing a stake of 13,023 shares — an estimated $655K sold.

Ballentine Partners first reported a position in ALKS in Q4 2013 and held it in 3 quarters. The position peaked at $655K in Q2 2014. 204 funds tracked by Wall St. Rank hold ALKS as of Q3 2014.

  • Ballentine Partners reported no remaining Alkermes position as of Q3 2014 after selling out during the quarter.
  • Ballentine Partners sold 13,023 Alkermes shares in Q3 2014, an estimated $655K.
  • Ballentine Partners first reported a position in Alkermes in Q4 2013 and held it in 3 quarters.
  • Ballentine Partners's Alkermes position peaked at $655K in Q2 2014.
  • 204 funds tracked by Wall St. Rank held Alkermes as of Q3 2014.

Based on Ballentine Partners's 13F filing for Q3 2014, filed 5 Nov 2014.